J&J Renews Bid To End Antitrust Suit From Walgreens, Kroger
Johnson & Johnson told a Pennsylvania federal judge Tuesday that Walgreens and Kroger can't bring antitrust claims against it for allegedly inflating prices and suppressing competition for its drug Remicade, reiterating its argument...To view the full article, register now.
Already a subscriber? Click here to view full article